Menu
GOVPH
  • Home
  • HTA Governance
    • Universal Health Care Act
    • Administrative Order on HTA
    • Philippine HTA Process Guide
    • Philippine HTA Methods Guide
    • Philippine HTA Code of Conduct
  • About Us
    • Mission/Vision
    • Health Technology Assessment Council (HTAC)
    • Health Technology Assessment Unit (HTAU)
    • HTA Philippines Annual Report
      • 2019 HTA Annual Report
      • 2020 HTA Annual Report
    • Road to HTA Institutionalization
    • External Partners
  • Assessments
    • Status of Assessments
    • Timeline of Assessments
      • Major Application
        • Expedited
          • COVID-19 Vaccines
          • Other COVID-19 Health Technologies
        • Urgent
        • General
      • Minor Application
  • Issuances
  • Evidence Briefs
  • FAQs
  • Get Involved with Us
    • Contact Us
    • Call for Nomination
    • Call for Interested Parties
    • Topic Nomination
  • AUXILIARY MENU
  • GOVPH
  • Home
  • HTA Governance
    • Universal Health Care Act
    • Administrative Order on HTA
    • Philippine HTA Process Guide
    • Philippine HTA Methods Guide
    • Philippine HTA Code of Conduct
  • About Us
    • Mission/Vision
    • Health Technology Assessment Council (HTAC)
    • Health Technology Assessment Unit (HTAU)
    • HTA Philippines Annual Report
      • 2019 HTA Annual Report
      • 2020 HTA Annual Report
    • Road to HTA Institutionalization
    • External Partners
  • Assessments
    • Status of Assessments
    • Timeline of Assessments
      • Major Application
        • Expedited
          • COVID-19 Vaccines
          • Other COVID-19 Health Technologies
        • Urgent
        • General
      • Minor Application
  • Issuances
  • Evidence Briefs
  • FAQs
  • Get Involved with Us
    • Contact Us
    • Call for Nomination
    • Call for Interested Parties
    • Topic Nomination

Assessment

Two-dose Inactivated Polio Vaccine (IPV) versus One-dose IPV for the prevention of Poliomyelitis

Tenofovir/Lamivudine/Dolutegravir (TLD) for treatment-naive and treatment-experienced adolescents and adults living with HIV

Lapatinib in treatment of HER2-positive breast cancer patients

Use of Rapid Antigen Test Kits for the Diagnosis of COVID-19 (April 2021 Assessment)

Janssen Ad26.COV2.S (COVID-19) Vaccine for the prevention of COVID-19

Sputnik V Gam-COVID-Vac COVID-19 Vaccine for the prevention of COVID-19

SARS-CoV-2 Vaccine (Vero Cell), Inactivated [CoronaVac] for the prevention of COVID-19

COVID -19 Vaccines

COVID-19 Vaccine (ChAdOx1-S [recombinant]) (COVID-19 Vaccine AstraZeneca) for the prevention of COVID-19

BNT162b2 (Pfizer-BioNTech COVID-19 Vaccine) for the prevention of COVID-19

Post navigation

← Older posts
480313
Users Today : 37
This Month : 28264
Total Users : 480312
Your IP Address : 54.175.165.101
Philippine Standard Time:
✕

Philippine Society of Microbiology and Infectious Diseases (PSMID) releases Philippine COVID-19 Living Recommendations

View the document on their website: https://www.psmid.org/philippine-covid-19-living-recommendations/